Your account is not claimed yet. You can sign up with ORCID to claim your account.

James N Fullerton (J N Fullerton)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Immune Response

Metabolic Syndrome

Peripheral Blood

Top Venues

British journal of clinical pharmacology

Clinical and translational science

The Journal of experimental medicine

University College London Hospitals NHS Foundation Trust

University College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Hospitals NHS Foundation Trust

United Kingdom

NIHR Clinical Lecturer :: Clinical Pharmacology and Therapeutics

Education History

University College London

United Kingdom

PHD :: Medicine

Publications

Helen Higham, L Morgan, C Cooper, J Marshall, A Mawer, S Jackson, R Lopez Ramon, E Hughes, D Richards, H McShane, James N Fullerton
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2. British journal of clinical pharmacology (2023)
Philip George Drennan, Dimitrios Karponis, Duncan B Richards, Mark Coles, James N Fullerton
In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review. Clinical and translational science (2022)
James N Fullerton, Oscar Della Pasqua, Robert Likić
Model antibiotic use to improve outcomes. British journal of clinical pharmacology 87 (3) (2020)
Amit A Patel, Yan Zhang, James N Fullerton, Lies Boelen, Anthony Rongvaux, Alexander A Maini, Venetia Bigley, Richard A Flavell, Derek W Gilroy, Becca Asquith, Derek C Macallan, Simon Yona
The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. The Journal of experimental medicine 214 (7) (2017)